Lowe Wealth Advisors, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 117 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lowe Wealth Advisors, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$1,000
-50.0%
1000.0%0.00%0.0%
Q4 2019$2,0000.0%1000.0%0.00%0.0%
Q3 2019$2,0000.0%1000.0%0.00%0.0%
Q2 2019$2,0000.0%1000.0%0.00%0.0%
Q1 2019$2,0000.0%1000.0%0.00%0.0%
Q4 2018$2,0000.0%1000.0%0.00%0.0%
Q3 2018$2,0000.0%1000.0%0.00%0.0%
Q2 2018$2,0000.0%1000.0%0.00%0.0%
Q1 2018$2,0000.0%1000.0%0.00%0.0%
Q4 2017$2,0000.0%1000.0%0.00%0.0%
Q3 2017$2,0001000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders